Literature DB >> 18806178

Policy-makers' attitudes to decision support models for coronary heart disease: a qualitative study.

David Taylor-Robinson1, Beth Milton, Ffion Lloyd-Williams, Martin O'Flaherty, Simon Capewell.   

Abstract

OBJECTIVES: To explore attitudes to the use of models for coronary heart disease to support decision-making for policy and service planning.
METHODS: Qualitative study using semi-structured interviews with 33 policy- and decision-makers purposively sampled from the UK National Health Service (NHS) (national, regional and local levels), academia and voluntary organizations. Interviews were transcribed, coded and emergent themes identified using framework analysis aided by NVivo software.
RESULTS: Policy-makers and planners were generally enthusiastic about models to assist in decision-making through: predicting trends; assessing the effect of interventions on health inequalities; quantifying the impact of population level and targeted interventions, and facilitating economic evaluation. The perceived advantages of using models included: more rational commissioning; the facility for scenario testing; advocacy for population level interventions and off-the-shelf synthesis to aid real time decision-making. However, although participants were aware of models to support decision-making, these were not being used routinely. Some participants felt that models oversimplify complex situations and that there is a lack of shared understanding as to how models work. Factors that increase confidence in decision support models included: rigorous validation and peer review, the availability of user-support and increased transparency.
CONCLUSION: Policy-makers and planners were generally enthusiastic about the use of models to support decision-making, illustrating the potential uses for models and the factors that improve confidence in them. However, existing models are often not being used in practice. So new models that are fit for practice need to be developed.

Entities:  

Mesh:

Year:  2008        PMID: 18806178     DOI: 10.1258/jhsrp.2008.008045

Source DB:  PubMed          Journal:  J Health Serv Res Policy        ISSN: 1355-8196


  6 in total

1.  Use of evidence to support healthy public policy: a policy effectiveness-feasibility loop.

Authors:  Sarah Bowman; Nigel Unwin; Julia Critchley; Simon Capewell; Abdullatif Husseini; Wasim Maziak; Shahaduz Zaman; Habiba Ben Romdhane; Fouad Fouad; Peter Phillimore; Belgin Unal; Rana Khatib; Azza Shoaibi; Balsam Ahmad
Journal:  Bull World Health Organ       Date:  2012-09-14       Impact factor: 9.408

Review 2.  The use of research evidence in public health decision making processes: systematic review.

Authors:  Lois Orton; Ffion Lloyd-Williams; David Taylor-Robinson; Martin O'Flaherty; Simon Capewell
Journal:  PLoS One       Date:  2011-07-26       Impact factor: 3.240

3.  The Health Equity and Effectiveness of Policy Options to Reduce Dietary Salt Intake in England: Policy Forecast.

Authors:  Duncan O S Gillespie; Kirk Allen; Maria Guzman-Castillo; Piotr Bandosz; Patricia Moreira; Rory McGill; Elspeth Anwar; Ffion Lloyd-Williams; Helen Bromley; Peter J Diggle; Simon Capewell; Martin O'Flaherty
Journal:  PLoS One       Date:  2015-07-01       Impact factor: 3.240

4.  A comparative analysis of potential spatio-temporal access to palliative care services in two Canadian provinces.

Authors:  Nadine Schuurman; Ofer Amram; Valorie A Crooks; Rory Johnston; Allison Williams
Journal:  BMC Health Serv Res       Date:  2015-07-17       Impact factor: 2.655

5.  Planning ahead in public health? A qualitative study of the time horizons used in public health decision-making.

Authors:  David C Taylor-Robinson; Beth Milton; Ffion Lloyd-Williams; Martin O'Flaherty; Simon Capewell
Journal:  BMC Public Health       Date:  2008-12-18       Impact factor: 3.295

6.  Perspectives on econometric modelling to inform policy: a UK qualitative case study of minimum unit pricing of alcohol.

Authors:  Srinivasa V Katikireddi; Lyndal Bond; Shona Hilton
Journal:  Eur J Public Health       Date:  2013-12-23       Impact factor: 3.367

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.